Canada markets close in 2 hours 1 minute

Aridis Pharmaceuticals, Inc. (ARDS)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
2.2400-0.0500 (-2.18%)
As of 01:35PM EDT. Market open.
Currency in USD
Earnings EstimateCurrent Qtr. (Jun 2022)Next Qtr. (Sep 2022)Current Year (2022)Next Year (2023)
No. of Analysts2222
Avg. Estimate-0.06-0.07-0.33-0.6
Low Estimate-0.49-0.49-1.95-1.4
High Estimate0.370.341.280.2
Year Ago EPS-0.49-1.94-3.85-0.33
Revenue EstimateCurrent Qtr. (Jun 2022)Next Qtr. (Sep 2022)Current Year (2022)Next Year (2023)
No. of Analysts2222
Avg. Estimate10.46M11.32M43.92M28.6M
Low Estimate520k550k2.84M1.5M
High Estimate20.4M22.1M85M55.7M
Year Ago Sales33k515k1.53M43.92M
Sales Growth (year/est)31,597.00%2,098.10%2,761.20%-34.90%
Earnings History2021-06-292021-09-292021-12-302022-03-30
EPS Est.-0.63-0.51-0.41-0.51
EPS Actual-0.49-1.94-0.92-0.44
Difference0.14-1.43-0.510.07
Surprise %22.20%-280.40%-124.40%13.70%
EPS TrendCurrent Qtr. (Jun 2022)Next Qtr. (Sep 2022)Current Year (2022)Next Year (2023)
Current Estimate-0.06-0.07-0.33-0.6
7 Days Ago-0.06-0.07-0.33-0.6
30 Days Ago-0.06-0.07-0.33-0.6
60 Days Ago-0.06-0.07-0.33-0.6
90 Days Ago-0.46-0.38-1.6-0.1
EPS RevisionsCurrent Qtr. (Jun 2022)Next Qtr. (Sep 2022)Current Year (2022)Next Year (2023)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesARDSIndustrySector(s)S&P 500
Current Qtr.87.80%N/AN/AN/A
Next Qtr.96.40%N/AN/AN/A
Current Year91.40%N/AN/AN/A
Next Year-81.80%N/AN/AN/A
Next 5 Years (per annum)59.10%N/AN/AN/A
Past 5 Years (per annum)N/AN/AN/AN/A